08.22.24 -- Will Lineage Become The Amazon Of Cell Therapy?

Join us on August 26th to learn how reducing early phase inefficiencies can lower initial investments, significantly lower operations costs, and increase productivity. We will share case studies focused on benchmark testing, using surrogate materials, controlled rate freezing, and at line analytics, to identify potential impacts critical to quality, faster and without extensive analytic burden. Click here to learn more.

AI and machine learning are the buzzwords of the decade, often accompanied by lofty promises — but what do they really mean for biopharma? How can these technologies be adopted to improve biomanufacturing processes, testing, and quality? Join Bioprocess Online Live for an exploration into the practical applications of AI/ML in biomanufacturing, its barriers to adoption, and how regulators can help standardize use across the industry. Registration is free thanks to the support of Atum Bio.